Table 3.
In vitro MIC results with associated therapeutic dosage.
| Treatment | In vitro MIC (μg/mL) | > × 10 (μg /mL) | Antibiotic dosage × 100 (μg/mL) | Final larval Dosage (μg/larva) | Larval survival (% ± SD) |
|---|---|---|---|---|---|
| + Control | 0 | 73.61 ± 6.36 | |||
| - Control | 0 | 100 ± 0 | |||
| Penicillin G | 0.18 | 5 | 500 | 5 | 68.06 ± 15.77* |
| Bacitracin | 1.56 | 15.6 | 1600 | 16 | 94.45 ± 4.8* |
| Neomycin | 60 | 600 | 60,000 | 600 | 65.28 ± 18.78 |
| Tetracycline | 1.56 | 15.6 | 1600 | 16 | 79.17 ± 14.43 |
Survival percentages ± Standard deviation after 72 h of being treated with 10 μL injected doses of 10 ×in vitro MIC against 10μL injection of 107 JBCNJ055. “+” indicates no treatment administered. “-” indicates infection with 0.1% peptone water as trauma controls. ∗Significantly different when compared to + control (P > 0.05) (Man–Whitney U-test).